Showing results (351-360 of 546) with videos related to
Sort By:
Pageof 55
American Journal of Medical Genetics|July 15, 1994
Reliability of diagnostic assessment of normal and premutation status in the fragile X syndrome using DNA testingG S Fisch, D L Nelson, K Snow, et al.The Journal of Clinical Investigation|April 20, 1999
Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndromeA Jain, T P Atkinson, P E Lipsky, et al.American Journal of Human Genetics|February 17, 2001
Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma)S Aradhya, G Courtois, A Rajkovic, et al.Poultry Science|August 30, 2008
Effect of aging on bioactive amines, microbial flora, physico-chemical characteristics, and tenderness of broiler breast meatA P S Moreira, A Giombelli, R A Labanca, et al.Human Molecular Genetics|March 1, 1996
Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndromeE E Eichler, J N Macpherson, A Murray, et al.Molecular and Cellular Biology|August 1, 1987
Chromosome-mediated transfer of the murine Na,K-ATPase alpha subunit confers ouabain resistanceD Fallows, R B Kent, D L Nelson, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1987
Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytesW Holter, C K Goldman, L Casabo, et al.BMC Plant Biology|August 12, 2024
Comparative analyses suggest a link between mRNA splicing, stability, and RNA covalent modifications in flowering plantsKyle Palos, Anna C Nelson Dittrich, Eric H Lyons, et al.European Journal of Pharmacology|October 26, 2000
LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodoneI A Pullar, S L Carney, E M Colvin, et al.Pediatric Nephrology (Berlin, Germany)|October 1, 1993
Serum and urine soluble interleukin-2 receptor in idiopathic nephrotic syndromeG H Bock, J R Ongkingco, L T Patterson, et al.Pageof 55